sertraline HCl tablets, 25 mg, 30 Tablets, Rx only, GREENSTONE BRAND --- Distributed by: Greensto...

FDA Drug Recall #D-746-2014 — Class II — November 5, 2013

Recall Summary

Recall Number D-746-2014
Classification Class II — Moderate risk
Date Initiated November 5, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Greenstone LLC
Location Peapack, NJ
Product Type Drugs
Quantity 585,096 bottles

Product Description

sertraline HCl tablets, 25 mg, 30 Tablets, Rx only, GREENSTONE BRAND --- Distributed by: Greenstone LLC, Peapack, NJ 07977 -- MADE IN INDIA --- NDC 59762-4960-1

Reason for Recall

Labeling: Incorrect or Missing Lot No. and/or Exp Date: Expiration date incorrectly reflects a 36 month shelf life, instead of the 24 month shelf life

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot SASA12001-A, exp. date 06/2015; Lot SASA12001-B, exp. date 06/2015; Lot SASA13001-A, exp. date 02/2016; Lot SASA13002-A, exp. date 02/2016

Other Recalls from Greenstone LLC

Recall # Classification Product Date
D-0299-2026 Class II methylprednisolone tablets, USP Dosepak, 4 mg, ... Jan 15, 2026
D-1361-2014 Class I Venlafaxine HCl Extended-Release Capsules, 150 ... Mar 6, 2014
D-1059-2014 Class III Glipizide XL (glipizide) extended release table... Nov 4, 2013
D-737-2014 Class II Nifedipine, extended-release tablets, 90mg 100 ... Nov 1, 2013
D-010-2014 Class II Spironolactone tablets, USP 25 mg, Rx only, 500... Sep 4, 2013

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.